The effect of infliximab on antiviral antibody profiles in patients with rheumatoid arthritis
β Scribed by Ilana Kaufman; Yolanda Braun Moscovici; Yair Abudi; Denit Sofer; Ella Mendelson; Alexandra Balbir-Gurman; Dan Caspi; Ori Elkayam
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 206 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0172-8172
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To investigate the effect of infliximab treatment on antinuclear antibodies (ANAs), antiβdoubleβstranded DNA (antiβdsDNA), antinucleosome, antihistone, and antiβextractable nuclear antigen (antiβENA) antibodies in rheumatoid arthritis (RA) and spondylarthropathy (SpA) pati
In patients with rheumatoid arthritis (RA) a decrease in the terminal galactose content of N-linked glycans of the Fc region of agalactosyl immunoglobulin G (IgG) (G0) occurs. The aim of this study was to evaluate, for the first time, the effect of infliximab, a new monoclonal antibody for the treat
## Abstract ## Objective According to the Centers for Disease Control and Prevention, the 1999 and 2000 incidence rates for tuberculosis (TB) in the US population were 6.4 and 5.8, respectively, per 100,000 persons. Recently, reports of TB following infliximab administration have raised questions